South African variant can ‘break through’ Pfizer vaccine, Israeli study says
Photo: Credit Reuters By Maayan Lubell JERUSALEM (Reuters) – The coronavirus variant discovered in South Africa can “break through” Pfizer/BioNTech’s COVID-19 vaccine to some extent, a real-world data study in Israel found, though its prevalence in the country is low and the research has not been peer reviewed. The study, released on Saturday, compared almost
Read More